Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Pre-analytical parameters associated with unsuccessful karyotyping in myeloid neoplasm: a study of 421 samples.

Santos MFM, Oliveira FCAC, Kishimoto RK, Borri D, Santos FPS, Campregher PV, Silveira PAA, Hamerschlak N, Mangueira CLP, Duarte FB, Crepaldi AH, Salvino MA, Velloso EDRP.

Braz J Med Biol Res. 2019 Feb 14;52(2):e8194. doi: 10.1590/1414-431X20188194.

2.

Diffuse large B-cell lymphoma of the central nervous system presenting as "lymphomatosis cerebri" and dementia in elderly man: Case report and review of the literature.

Kerbauy MN, Pasqualin DDC, Smid J, Iquizli R, Kerbauy LN, Nitrini R, Ribas GC, Neder L, Hamerschlak N.

Medicine (Baltimore). 2019 Feb;98(6):e14367. doi: 10.1097/MD.0000000000014367.

3.

Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?

Nucci M, Shoham S, Abdala E, Hamerschlak N, Rico JC, Forghieri F, Nouér SA, Cappellano P, Solza C, Gonzaga Y, Nadali G, Nucci F, Colombo AL, Albuquerque AM, Queiroz-Telles Filho F, Lima CBL, Arrais-Rodrigues C, Rocha V, Marty FM.

Mycoses. 2019 Feb 5. doi: 10.1111/myc.12901. [Epub ahead of print]

PMID:
30720902
4.

Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma.

O'Connor OA, Özcan M, Jacobsen ED, Roncero JM, Trotman J, Demeter J, Masszi T, Pereira J, Ramchandren R, Beaven A, Caballero D, Horwitz SM, Lennard A, Turgut M, Hamerschlak N, d'Amore FA, Foss F, Kim WS, Leonard JP, Zinzani PL, Chiattone CS, Hsi ED, Trümper L, Liu H, Sheldon-Waniga E, Ullmann CD, Venkatakrishnan K, Leonard EJ, Shustov AR; Lumiere Study Investigators.

J Clin Oncol. 2019 Feb 1:JCO1800899. doi: 10.1200/JCO.18.00899. [Epub ahead of print]

PMID:
30707661
5.

Hepatic and cardiac and iron overload detected by T2* magnetic resonance (MRI) in patients with myelodisplastic syndrome: A cross-sectional study.

Mantovani LF, Santos FPS, Perini GF, Nascimento CMB, Silva LP, Wroclawski CK, Esposito BP, Ribeiro MSS, Velloso EDRP, Nomura CH, Kay FU, Baroni RH, Hamerschlak N, Schuster S.

Leuk Res. 2019 Jan;76:53-57. doi: 10.1016/j.leukres.2018.12.001. Epub 2018 Dec 4.

PMID:
30572266
6.

Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countries.

Fernandes JF, Nichele S, Daudt LE, Tavares RB, Seber A, Kerbauy FR, Koliski A, Loth G, Vieira AK, Darrigo-Junior LG, Rocha V, Gomes AA, Colturato V, Mantovani LF, Ribeiro AF, Ribeiro LL, Kuwahara C, Rodrigues ALM, Zecchin VG, Costa-Carvalho BT, Carneiro-Sampaio M, Condino-Neto A, Fasth A, Gennery A, Pasquini R, Hamerschlak N, Bonfim C.

J Clin Immunol. 2018 Nov;38(8):917-926. doi: 10.1007/s10875-018-0564-1. Epub 2018 Nov 24.

PMID:
30470982
7.

ZAP-70 expression is associated with increased CD4 central memory T cells in chronic lymphocytic leukemia: cross-sectional study.

Correia RP, Matos E Silva FA, Bacal NS, Campregher PV, Hamerschlak N, Amarante-Mendes GP.

Hematol Transfus Cell Ther. 2018 Oct-Dec;40(4):317-325. doi: 10.1016/j.htct.2018.03.008. Epub 2018 Jun 11.

8.

Overall survival of Brazilian acute myeloid leukemia patients according to the European LeukemiaNet prognostic scoring system: a cross-sectional study.

Datoguia TS, Velloso EDRP, Helman R, Musacchio JG, Salvino MA, Soares RA, Higashi M, Fadel AV, E Silva RSA, Hamerschlak N, Santos FPS, Campregher PV.

Med Oncol. 2018 Sep 5;35(11):141. doi: 10.1007/s12032-018-1179-3.

PMID:
30187210
9.

Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient.

Eduardo FP, Bezinelli LM, Gobbi M, Rosin FCP, Carvalho DLC, Ferreira MH, da Silva CC, Hamerschlak N, Corrêa L.

Support Care Cancer. 2019 Mar;27(3):839-848. doi: 10.1007/s00520-018-4362-3. Epub 2018 Aug 14.

PMID:
30109488
10.

Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.

Clé DV, Atta EH, Dias DSP, Lima CBL, Bonduel M, Sciuccati G, Medeiros LA, de Oliveira MM, Blum Fonseca PB, Saad STO, Hamerschlak N, Salvino MA, Garanito MP, Pazin-Filho A, Scheinberg P, Calado RT.

Ann Hematol. 2018 Nov;97(11):2039-2046. doi: 10.1007/s00277-018-3416-4. Epub 2018 Jul 5.

PMID:
29978284
11.

International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections.

Hachem R, Kanj S, Hamerschlak N, Saad H, Assir FF, Mori N, Jiang Y, Ghaly F, Chaftari AM, Raad II.

Expert Rev Med Devices. 2018 Jun;15(6):461-466. doi: 10.1080/17434440.2018.1483237.

PMID:
29927699
12.

BCL-2 as therapeutic target for hematological malignancies.

Perini GF, Ribeiro GN, Pinto Neto JV, Campos LT, Hamerschlak N.

J Hematol Oncol. 2018 May 11;11(1):65. doi: 10.1186/s13045-018-0608-2. Review.

13.

Reclassification of risk in an emergency referral center: the need for a specific tool for the classification of onco-hematological patients. A cross-sectional study.

Manfredini LL, Dos Santos GP, Centrone AFY, Hamerschlak N.

Med Oncol. 2018 May 4;35(6):86. doi: 10.1007/s12032-018-1136-1.

PMID:
29728932
14.

The impact of preapheresis white blood cell count on autologous peripheral blood stem cell collection efficiency and HSC infusion side effect rate.

Sakashita AM, Kondo AT, Yokoyama APH, Lira SMC, Bub CB, Souza AM, Cipolletta ANF, Alvarez KC, Hamerschlak N, Kutner JM, Chiattone CS.

J Clin Apher. 2018 Jun;33(3):331-341. doi: 10.1002/jca.21614. Epub 2018 Jan 19.

PMID:
29350425
15.

Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.

Fernandes JF, Bonfim C, Kerbauy FR, Rodrigues M, Esteves I, Silva NH, Azambuja AP, Mantovani LF, Kutner JM, Loth G, Kuwahara CC, Bueno C, Kondo AT, Ribeiro AAF, Kok F, Hamerschlak N.

Bone Marrow Transplant. 2018 Apr;53(4):392-399. doi: 10.1038/s41409-017-0015-2. Epub 2018 Jan 12.

PMID:
29330393
16.

Impact of Oral and Gastrointestinal Mucositis on Body Weight Alterations during Hematopoietic Stem Cell Transplantation.

Eduardo FP, Bezinelli LM, Gobbi MF, Pereira AZ, Vogel C, Hamerschlak N, Corrêa L.

Nutr Cancer. 2018 Feb-Mar;70(2):241-248. doi: 10.1080/01635581.2018.1412476. Epub 2017 Dec 26.

PMID:
29278934
17.

A review of data in medical request and the patient questionnaire for magnetic resonance evaluation of silicone breast implants.

Anger J, Elias PE, Moraes PC, Hamerschlak N.

Einstein (Sao Paulo). 2017 Oct-Dec;15(4):465-469. doi: 10.1590/S1679-45082017AO4147. Epub 2017 Dec 18. English, Portuguese.

18.

BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy.

Pereira WO, De Carvalho DD, Zenteno ME, Ribeiro BF, Jacysyn JF, Sardinha LR, Zanichelli MA, Hamerschlak N, Jones GE, Pagnano KB, Castro FA, Calle Y, Amarante-Mendes GP.

Cell Death Dis. 2017 Oct 12;8(10):e3114. doi: 10.1038/cddis.2017.458.

19.

Comparison of different laboratory tests in the evaluation of hemorrhagic risk of patients using rivaroxaban in the critical care setting: diagnostic accuracy study.

Colombini MP, Derogis PBMC, de Aranda VF, de Campos Guerra JC, Hamerschlak N, Mangueira CLP.

Thromb J. 2017 Aug 15;15:21. doi: 10.1186/s12959-017-0140-6. eCollection 2017.

20.

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.

Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E, Bashir Q, Cashen A, Couriel D, Diez-Martin J, Katsanis E, Linhares Y, Mori S, Nash R, Pawarode A, Perales MA, Phipps CD, Richman C, Savani BN, Shapira MY, Stiff P, Strair R, Fenske TS, Smith SM, Sureda A, Olteanu H, Hamadani M.

Br J Haematol. 2018 Sep;182(6):916-920. doi: 10.1111/bjh.14879. Epub 2017 Aug 2. No abstract available.

PMID:
28771676
21.

Ferritin light chain gene mutations in two Brazilian families with hereditary hyperferritinemia-cataract syndrome.

Petroni RC, Rosa SEAD, Carvalho FP, Santana RAF, Hyppolito JE, Nascimento CMDB, Hamerschlak N, Campregher PV.

Einstein (Sao Paulo). 2017 Oct-Dec;15(4):492-495. doi: 10.1590/S1679-45082017RC4006. Epub 2017 Jul 24. English, Portuguese.

22.

Successful treatment of post-transplant relapsed acute myeloid leukemia with FLT3 internal tandem duplication using the combination of induction chemotherapy, donor lymphocyte infusion, sorafenib and azacitidine. Report of three cases.

Campregher PV, Mattos VRP, Salvino MA, Santos FPS, Hamerschlak N.

Einstein (Sao Paulo). 2017 Jul-Sep;15(3):355-358. doi: 10.1590/S1679-45082017RC3784. Epub 2017 Jul 24. English, Portuguese.

23.

Therapeutic salivary monitoring of IV busulfan in patients undergoing hematopoietic stem cell transplantation: a pilot study.

Bezinelli LM, Eduardo FP, de Carvalho DLC, Dos Santos Ferreira CE, de Almeida EV, Sanches LR, Esteves I, Campregher PV, Hamerschlak N, Corrêa L.

Bone Marrow Transplant. 2017 Oct;52(10):1384-1389. doi: 10.1038/bmt.2017.142. Epub 2017 Jul 24.

PMID:
28737776
24.

Survival, toxicity and length of stay after haploidentical or cord blood transplantation in a Latin American center: a cross-sectional, comparative study.

Esteves I, Santos FPS, Ribeiro AAF, Kondo AT, Fernandes JF, Kerbauy FR, Kerbauy L, Hamerschlak N.

Blood Cancer J. 2017 May 26;7(5):e563. doi: 10.1038/bcj.2017.44. No abstract available.

25.

Identification of a novel fusion TBL1XR1-PDGFRB in a patient with acute myeloid leukemia harboring the DEK-NUP214 fusion and clinical response to dasatinib.

Campregher PV, Halley NDS, Vieira GA, Fernandes JF, Velloso EDRP, Ali S, Mughal T, Miller V, Mangueira CLP, Odone V, Hamerschlak N.

Leuk Lymphoma. 2017 Dec;58(12):2969-2972. doi: 10.1080/10428194.2017.1318437. Epub 2017 May 16. No abstract available.

PMID:
28509585
26.

Chronic lymphocytic leukemia in Brazil: A retrospective analysis of 1903 cases.

Gonçalves MV, Rodrigues CA, Lorand Metze IGH, Lacerda MP, de Lourdes Lopes Ferrari Chauffaille M, Azevedo A, Machado C, Chiattone CS, Fortier S, Perobelli L, Ikoma MRV, Clementino N, Hamerschlak N, Sthel VM, Ommati LVM, de Farias DLC, Duarte FB, Buccheri V, de Azambuja AP, de Almeida DR, Figueiredo VLP, Yamamoto M.

Am J Hematol. 2017 Aug;92(8):E171-E173. doi: 10.1002/ajh.24779. Epub 2017 Jun 9. No abstract available.

27.

A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.

José FF, Kerbauy LN, Perini GF, Blumenschein DI, Pasqualin DD, Malheiros DM, Campos Neto GC, de Souza Santos FP, Piovesan R, Hamerschlak N.

Medicine (Baltimore). 2017 Mar;96(13):e6271. doi: 10.1097/MD.0000000000006271.

28.

A Child as a Donor for Hematopoietic Stem Cell Transplantation: Bioethical Justification-A Case Study on Sickle Cell Disease.

Pereira AZ, Hellman R, Hamerschlak N, Kondo A, de Souza PM, Pedreira WL Jr, Mantovani LF, Troster EJ, Grunspun H, Bueno MA.

Case Rep Hematol. 2017;2017:8394732. doi: 10.1155/2017/8394732. Epub 2017 Feb 23.

29.

Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation.

Dotoli GM, De Santis GC, Orellana MD, de Lima Prata K, Caruso SR, Fernandes TR, Rensi Colturato VA, Kondo AT, Hamerschlak N, Simões BP, Covas DT.

Bone Marrow Transplant. 2017 Jun;52(6):859-862. doi: 10.1038/bmt.2017.35. Epub 2017 Mar 13.

PMID:
28287644
30.

Paradoxes of hematology: When the old disappears and the new does not arrive.

Maiolino A, Simões BP, de Castro CG Junior, Covas DT, Dos Santos Fernandes G, Hamerschlak N, Fonseca TC, Colturato V.

Rev Bras Hematol Hemoter. 2017 Jan - Mar;39(1):1-3. doi: 10.1016/j.bjhh.2017.01.001. Epub 2017 Jan 23. No abstract available.

31.

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.

Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, Moraes DA, Nash RA, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnený M, Zhu L, Badoglio M, Zhong X, Sormani MP, Saccardi R; Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group.

JAMA Neurol. 2017 Apr 1;74(4):459-469. doi: 10.1001/jamaneurol.2016.5867.

32.

Human Leukocyte Antigen-Haploidentical Transplantation for Relapsed/Refractory Hodgkin Lymphoma: A Multicenter Analysis.

Lacerda MP, Arrais Rodrigues C, Pereira AD, Novis Y, Fonseca M, Silva RL, Macedo MCMA, Hamerschlak N, Esteves I, Schmidt Filho J, Nascimento MM, Rocha V.

Biol Blood Marrow Transplant. 2017 Apr;23(4):705-707. doi: 10.1016/j.bbmt.2017.01.079. Epub 2017 Jan 17.

33.

Challenges and opportunities in primary CNS lymphoma: A systematic review.

Kerbauy MN, Moraes FY, Lok BH, Ma J, Kerbauy LN, Spratt DE, Santos FP, Perini GF, Berlin A, Chung C, Hamerschlak N, Yahalom J.

Radiother Oncol. 2017 Mar;122(3):352-361. doi: 10.1016/j.radonc.2016.12.033. Epub 2017 Jan 16. Review.

PMID:
28104300
34.

A Novel Assay for the Identification of NOTCH1 PEST Domain Mutations in Chronic Lymphocytic Leukemia.

Campregher PV, Petroni RC, Muto NH, Sitnik R, de Carvalho FP, Bacal NS, Velloso ED, Oliveira GB, Pinho JR, Torres DC, Mansur MB, Hassan R, Lorand-Metze IG, Chiattone CS, Hamerschlak N, Mangueira CL.

Biomed Res Int. 2016;2016:4247908. doi: 10.1155/2016/4247908. Epub 2016 Dec 15.

35.

Haploidentical transplantation of hematopoietic stem cells.

Hamerschlak N.

Rev Assoc Med Bras (1992). 2016 Oct;62 Suppl 1:29-33. Review.

36.

Tribute to 100 years of Professor Dr. Michel Abu Jamra.

Hamerschlak N, Filho VO.

Rev Bras Hematol Hemoter. 2016 Oct - Dec;38(4):277-278. doi: 10.1016/j.bjhh.2016.09.002. Epub 2016 Sep 21. No abstract available.

37.

Observational study of multiple myeloma in Latin America.

Hungria VT, Maiolino A, Martinez G, Duarte GO, Bittencourt R, Peters L, Colleoni G, Oliveira LC, Crusoé E, Coelho ÉO, Pasquini R, Magalhães SM, Nunes R, Neto JV, Faria RM, Souza M, Hamerschlak N, Flantl D, Navarro JR, Conte G, Gomez-Almaguer D, Ruiz-Argüelles G, Durie BG; International Myeloma Working Group Latin America.

Ann Hematol. 2017 Jan;96(1):65-72. doi: 10.1007/s00277-016-2866-9. Epub 2016 Nov 5.

PMID:
27815724
38.

Tumor mass in the palate after bone marrow transplantation.

Bezinelli LM, de Paula Eduardo F, Marques da Graça Lopes R, Pasqualin DDC, Hamerschlak N, Corrêa L.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Aug;124(2):107-113. doi: 10.1016/j.oooo.2016.08.003. Epub 2016 Aug 6. No abstract available.

PMID:
27720657
39.

Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm.

Helman R, Pereira WO, Marti LC, Campregher PV, Puga RD, Hamerschlak N, Chiattone CS, Santos FPS.

Br J Haematol. 2018 Feb;180(3):443-445. doi: 10.1111/bjh.14327. Epub 2016 Sep 21. No abstract available.

PMID:
27650062
40.

Brazilian guidelines on hematopoietic stem cell transplantation in acute myeloid leukemia.

Silla L, Dulley F, Saboya R, Kerbauy F, de Moraes Arantes A, Pezzi A, Gross LG, Paton E, Hamerschlak N.

Eur J Haematol. 2017 Feb;98(2):177-183. doi: 10.1111/ejh.12808. Epub 2016 Oct 11.

PMID:
27621140
41.

Hematological approaches to multiple myeloma: trends from a Brazilian subset of hematologists. A cross-sectional study.

Kerbauy LN, Parmar S, Kutner JM, Gusmão BM, Hamerschlak N.

Sao Paulo Med J. 2016 Jul-Aug;134(4):335-41. doi: 10.1590/1516-3180.2015.0223030416.

42.

Diffuse large B cell gastric lymphoma a rare disease: the effort to obtain scientific data in a multicenter, multinational retrospective trial.

Hamerschlak N.

Rev Bras Hematol Hemoter. 2016 Jul-Sep;38(3):186-7. doi: 10.1016/j.bjhh.2016.05.014. Epub 2016 Jun 23. No abstract available.

43.

Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation.

Perini GF, Campregher PV, Ross JS, Ali S, Hamerschlak N, Santos FP.

Blood Cancer J. 2016 May 13;6:e420. doi: 10.1038/bcj.2016.25. No abstract available.

44.

Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.

Vasconcellos de Souza C, Vigorito AC, Miranda ECM, Garcia C Jr, Rensi Colturato VA, Mauad MA, Rodrigues Moreira MC, da Silva Bouzas LF, Lermontov S, Hamerschlak N, Rodrigues M, Carlos de Almeida Barros J, Chiattone R, Lee SJ, Flowers MED.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1313-1318. doi: 10.1016/j.bbmt.2016.03.013. Epub 2016 Apr 4.

45.

A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1-HAUS1.

Campregher PV, de Oliveira Pereira W, Lisboa B, Puga R, Deolinda ER, Helman R, Marti LC, Guerra JC, Manola KN, Petroni RC, Bezerra AM, Costa FF, Hamerschlak N, de Souza Santos FP.

Haematologica. 2016 Jul;101(7):e287-90. doi: 10.3324/haematol.2015.137364. Epub 2016 Apr 1. No abstract available.

46.

Clinical features of JAK2V617F- or CALR-mutated essential thrombocythemia and primary myelofibrosis.

Monte-Mor Bda C, Ayres-Silva Jde P, Correia WD, Coelho AC, Solza C, Daumas AH, Bonamino MH, Santos FP, Datoguia TS, Pereira Wde O, Lisboa BC, Ramos CF, Machado-Neto JA, Hamerschlak N, Campregher PV, Traina F, Pagnano KB, Zalcberg I.

Blood Cells Mol Dis. 2016 Sep;60:74-7. doi: 10.1016/j.bcmd.2016.03.003. Epub 2016 Mar 8. No abstract available.

PMID:
26994960
47.

Determination of an unrelated donor pool size for human leukocyte antigen-matched platelets in Brazil.

Bub CB, Torres MA, Moraes ME, Hamerschlak N, Kutner JM.

Rev Bras Hematol Hemoter. 2016 Jan-Feb;38(1):1-6. doi: 10.1016/j.bjhh.2015.10.005. Epub 2015 Nov 28.

48.

Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemia.

Pereira WO, Correia RP, Hamerschlak N, Bacal NS, Campregher PV.

Einstein (Sao Paulo). 2016 Mar 8;14(2):288-9. doi: 10.1590/S1679-45082016AI3516. English, Portuguese. No abstract available.

49.

HIGH BODY MASS INDEX AMONG PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS OF A CROSS-SECTIONAL EVALUATION OF NUTRITIONAL STATUS IN A PRIVATE HOSPITAL.

Pereira AZ, Victor ES, Vidal Campregher P, Piovacari SM, Bernardo Barban JS, Pedreira WL Jr, Hamerschlak N.

Nutr Hosp. 2015 Dec 1;32(6):2874-9. doi: 10.3305/nh.2015.32.6.9391.

50.

Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis.

Campregher PV, Pereira WO, Lisboa B, Puga R, Helman R, Miyagi M, da Mata EH, Datoguia TS, Velloso ED, Bacal NS, Ross JS, Ali S, Miller V, Costa FF, Hamerschlak N, Santos FP.

Mol Cancer. 2015 Nov 19;14:197. doi: 10.1186/s12943-015-0471-5.

Supplemental Content

Loading ...
Support Center